Table 2 Correlation of circ-NOLC1 expression with different clinicopathological features of ovarian carcinoma.

From: Circ-NOLC1 promotes epithelial ovarian cancer tumorigenesis and progression by binding ESRP1 and modulating CDK1 and RhoA expression

Clinicopathological features

N

circ-NOLC1 expression/18 s

P value

The pathology types

  

0.2795

   Serous carcinoma

86

2.20741E-05 ± 6.38584E-05

 

   The other pathology types

32

1.58183E-05 ± 4.60309E-05

 

Age

  

0.2531

   ≤52

62

2.38226E-05 ± 6.41964E-05

 

   >52

56

1.65634E-05 ± 5.39825E-05

 

CA125

  

0.0029

   ≤35 U/ml

9

3.97132E-06 ± 6.6421E-06

 

   >35 U/ml

109

2.17322E-05 ± 6.16323E-05

 

FIGO stages

  

0.0144

   I

22

6.29372E-06 ± 1.94561E-05

 

   II–IV

96

2.36051E-05 ± 6.48809E-05

 

Pathology classification

  

0.0018

   Well

18

3.39141E-06 ± 9.26029E-06

 

   Mod + poor

100

2.34351E-05 ± 6.40101E-05

 
  1. Bold and italics means P < 0.05.